Swedish Inflammatory Bowel Disease Conference June 1st, 2024

In-Person @ Hyatt Regency Bellevue, WA

 & Live Streaming

Send PDF
Just enter your email address and we will send you a PDF of the postcard. Please be sure to share it with your co-workers or enter their email address and we will send them this Save-the-Date PDF too.
Name
Name
First
Last

How to Attend

  • VIRTUAL - You can participate Virtually from your home or office
  • IN-PERSON - You can participate in person

How Much

  • $50 - In-Person or Virtual - includes 90 day access to the recordings

 

When

  • The Conference will held on June 1st, 2024
    - Recordings are available on demand until October 1, 2024

Where

Virtual

  • On this website -- you will be given a password to access the PDF's & recordings

Please join us for our annual Swedish IBD update on Saturday, June 1st, 2024!

*In-Person and Virtual -- We are offering this meeting as a Hybrid Webinar -- Just register and select in-person or virtual attendance. Remote connection information will be provided 3 days prior to the meeting.  Recordings and CME will be made available for 90 days for all participants.

The annual Swedish Providence Update in Inflammatory Bowel Disease course will review new and forthcoming medical and surgical therapeutic approaches in IBD and its associated manifestations, as well their impact on the current management of these conditions. The therapeutic landscape in IBD continues to evolve, resulting in rapid and dramatic changes to therapeutic algorithms and disease monitoring. The course will review the impact of positioning new therapeutics, optimization of medical therapy, disease management in the perioperative period, extraintestinal manifestations, dietary, nonpharmacologic therapies and multi-disciplinary approaches to complex clinical scenarios including strictures. It will also cover novel therapies including the advent of small molecules and their impact in the management of IBD patients.

Teaching methods include lecture/didactic, Q&A with faculty, panel discussion, case presentation and audience response system.

This year's keynote speaker is Dr. Remo Panaccione, Professor of Medicine, Director IBD Unit, University of Calgary, Canada.   Dr/Prof Remo Panaccione is a Professor of Medicine and the Director of the Inflammatory Bowel Disease Unit at the University of Calgary, Calgary, Canada. He serves as the Dean of MD Admissions and Director of the IBD Fellowship Program. He holds the Crohn’s Colitis Canada Endowed Research Chair in Inflammatory Bowel Disease. He serves as an executive member for the International Organization for the Study of IBD (IOIBD). He is the 2020 Crohn's Colitis Canada Outstanding Physician of the Year and has been recognized as a 2020-23 Clarivate Research Scholar for being cited in the top 1% of researchers in the world. He has co-authored over 350 manuscripts, 20 book chapters, and 625 abstracts including publications in journals such as the New England Journal of Medicine, Lancet, JAMA, Nature, and Annals of Internal Medicine.

"Education" Button on Modern Computer Keyboard.

Objectives

At the conclusion of this activity, participants should be able to:

  • Analyze and evaluate the latest evidence and identify the strengths and limitations of head-to-head clinical trials in IBD.
  • Learn how to apply the most recent evidence regarding mucosal healing, neoplasia surveillance and treatment optimization including combination advanced therapy for IBD in clinical practice
  • Learn about new medical treatment options in IBD and how they may affect the therapeutic landscape
  • Understand the role of the multi-disciplinary team including colorectal surgeon, gastroenterologist, nutritionist, pharmacist and psychologist for the management of patients with IBD
  • Review the evidence supporting the efficacy and safety of biosimilars in IBD

 

Webinar - full image - shutterstock_523917988

Who Should attend

Medical Professionals in:

  • Gastroenterology
  • General Practice
  • Hospitalist
  • Internal Medicine
  • OBGYN / Obstetrics & Gynecology
  • Radiology
  • Colorectal Surgery
  • General Surgery

2024 Accreditation Statement

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Well Assembled Meetings.  Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Amedco Joint Accreditation #4008163.

Physicians (ACCME) Credit Designation

Amedco LLC designates this live activity for a maximum of 7.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) Credit Designation

Amedco LLC designates this activity for a maximum of 7.00 ANCC contact hours.

Physician Assistants

PAs may claim a maximum of 7.00 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society.

 Nurse Practitioners

The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum 7.00 hours.

2024 Agenda (All times shown in Pacific Time Zone)

2024 Faculty

Michael Chiorean, MD

Seattle, WA

Course Director & Gastroenterologist, Inflammatory Bowel Disease Center, Swedish Medical Center

Karlee J. Ausk, MD

Seattle, WA

Course Co-Director & Gastroenterologist, Inflammatory Bowel Disease Center, Swedish Medical Center

Remo Panaccione, MD

Calgary, Alberta, Canada

Keynote Speaker - Professor of Medicine, Director IBD Unit, University of Calgary, Canada

Lulu Iles-Shih, MD

Seattle, WA

Specializes in Gastroenterology, Advanced Endoscopic Intervention, Internal medicine

Scott D. Lee, MD

Seattle, WA

Gastroenterologist, Associate Professor of Medicine, Director of Clinical Inflammatory Bowel Disease Program, University of Washington

Lindsay Sceats, MD

Seattle, WA

Colorectal Surgeon, Swedish Medical Center

Jesse Tegtmeyer

Seattle, WA

Pharmacist at Swedish Medical Center

Alina B. Wong, MD

Seattle, WA

Gastroenterologist specializing in inflammatory bowel disorders, Swedish Medical Center

Tim Zisman, MD

Seattle, WA

Gastroenterologist, Virginia Mason Medical Center